Children's Hospital Boston and Pfizer Enter Into Novel Collaborative Research Agreement for Muscular Dystrophy Therapeutics

BOSTON, Nov. 9, 2011 /PRNewswire via COMTEX/ -- Arrangement aims to
accelerate development of new therapies through unique exchange of expertise in
basic science and preclinical drug development


Children's Hospital Boston and Pfizer Inc. /quotes/zigman/238207/quotes/nls/pfe PFE
launched a new collaborative program aimed at identifying potential drug
therapies for Duchenne muscular dystrophy (DMD). At the heart of the one-year
collaborative research agreement is a novel exchange of expertise that brings
the respective strengths of academia and industry together in a framework that
could hold promise for benefitting DMD patients in the future.

Views: 225

Reply to This

Replies to This Discussion

Is there a paper published with the results of the 1200 drug screen mentioned in the article?

Reply to Discussion


Need help using this community site? Visit Ning's Help Page.



© 2022   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service